Loading...

Brilliant Violet 711™ anti-mouse Ly-6C Antibody

Pricing & Availability
Clone
HK1.4 (See other available formats)
Regulatory Status
RUO
Other Names
Lymphocyte antigen 6 complex, locus C
Isotype
Rat IgG2c, κ
Ave. Rating
Submit a Review
Product Citations
publications
HK1.4_BV711_LY-6C_Antibody_FC_100713
C57BL/6 mouse bone marrow cells were stained with Ly-6C (clone HK1.4) Brilliant Violet 711™ (filled histogram). Open histogram represents non-stained cells. Data shown was gated on the myeloid population.
  • HK1.4_BV711_LY-6C_Antibody_FC_100713
    C57BL/6 mouse bone marrow cells were stained with Ly-6C (clone HK1.4) Brilliant Violet 711™ (filled histogram). Open histogram represents non-stained cells. Data shown was gated on the myeloid population.
Compare all formats See Brilliant Violet 711™ spectral data
Cat # Size Price Save
128037 50 µg ¥62,920
Description

Most hematopoietic cells express one or more members of Ly-6 family. The expression of Ly-6 varies with development stage and activation. Ly-6C is a 14-17 kD GPI-linked surface protein expressed on mouse monocyte/macrophage cells, endothelial cells, neutrophils, and some T cell subsets. Ly-6C is reported to be an indicator of memory CD8+ T cells.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
L3 cloned CTL cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation
The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 711™ under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 µg per million cells in 100 µl volume or 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Brilliant Violet 711™ excites at 405 nm and emits at 711 nm. The bandpass filter 710/50 nm is recommended for detection, although filter optimization may be required depending on other fluorophores used. Be sure to verify that your cytometer configuration and software setup are appropriate for detecting this channel. Refer to your instrument manual or manufacturer for support. Brilliant Violet 711™ is a trademark of Sirigen Group Ltd.


Learn more about Brilliant Violet™.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.
Excitation Laser
Violet Laser (405 nm)
Application Notes

Clone HK1.4 does not block the binding of clone RB6-8C58.

Additional reported applications (for relevant formats of this clone) include: in vitro activation of T cells1-3 and immunohistochemistry of frozen sections4.

Application References

(PubMed link indicates BioLegend citation)
  1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819. (Activ)
  2. Herold KC, et al. 1990. Diabetes 39:815. (Activ)
  3. Havran WL, et al. 1988. J. Immunol. 140:1034 (Activ)
  4. Flanagan K, et al. 2008. J. Immunol. 180:3874. (IHC)
  5. Makaroff LE, et al. 2009. P. Natl. Acad. Sci. USA 106:4799. (FC)
  6. Zuber J, et al. 2009. Genes Dev. 23:877. (FC) PubMed
  7. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  8. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  9. Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
Product Citations
  1. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  2. Argüello RJ, et al. 2020. Cell Metab. 32:1063. PubMed
  3. Chen G, et al. 2021. J Mol Cell Cardiol. 159:62. PubMed
  4. Atalis A, et al. 2022. J Control Release. 347:476. PubMed
  5. Manda-Handzlik A, et al. 2022. Int J Mol Sci. 23: . PubMed
  6. Ostendorf BN, et al. 2022. Nature. 611:346. PubMed
  7. García-García A, et al. 2023. Bioact Mater. 24:174. PubMed
  8. Peng Y, et al. 2023. Respir Res. 24:33. PubMed
  9. Wu Q, et al. 2023. Cell Rep. 42:112057. PubMed
  10. Sohn J, et al. 2022. Blood Adv. 6:2557. PubMed
  11. Harapas CR, et al. 2022. Sci Immunol. 7:eabi4611. PubMed
  12. Jeon Y, et al. 2022. Cancers (Basel). 14:. PubMed
  13. Yashchenko A, et al. 2023. Front Immunol. 14:1082078. PubMed
  14. Cansever D, et al. 2023. Nat Immunol. . PubMed
  15. Friebel E, et al. 2020. Cell. 181(7):1626-1642.e20. PubMed
  16. Hagan N, et al. 2020. Cell Death Dis. 1.086111111. PubMed
  17. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  18. Hu W, et al. 2021. Nat Immunol. 22:1163. PubMed
  19. Chattopadhyay A, et al. 2018. Sci Rep. 8:9032. PubMed
  20. Evren E, et al. 2020. Immunity. 54(2):259-275.e7. PubMed
  21. Zhu B, et al. 2021. Immunity. 54(6):1200-1218.e9. PubMed
  22. Bhattacherjee A, et al. 2021. Mol Neurodegener. 16:19. PubMed
  23. Ostendorf BN, et al. 2020. Nat Med. 26:1048. PubMed
  24. Bhattacherjee A, et al. 2019. Commun Biol. 2:450. PubMed
  25. Jenkins RW, et al. 2018. Cancer Discov. 8:196. PubMed
  26. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  27. Dikiy S, et al. 2021. Immunity. 54(5):931-946.e11. PubMed
  28. Liang Z, et al. 2020. Pain. 161:2089. PubMed
  29. Goldman E, et al. 2021. Cells. 10:. PubMed
  30. Ruhland MK, et al. 2020. Cancer Cell. 37(6):786-799.e5. PubMed
  31. Kelsey E Sivick et al. 2018. Cell reports. 25(11):3074-3085 . PubMed
  32. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  33. Salvioni A et al. 2019. Cell Rep. 27(11):3254-3268 . PubMed
  34. Koivisto CS, et al. 2020. Neoplasia. 1.252777778. PubMed
  35. Guo P, et al. 2021. J Immunol. 207:408. PubMed
  36. Kennedy EM, et al. 2022. Nat Commun. 13:5907. PubMed
  37. Brandi P, et al. 2022. Cell Rep. 38:110184. PubMed
  38. Brown CC, et al. 2020. Cell. 179(4):846-863.e24.. PubMed
  39. Tavazoie MF, et al. 2018. Cell. 172:825. PubMed
  40. Campbell C et al. 2018. Immunity. 48(6):1245-1257 . PubMed
  41. Van Winkle JA et al. 2018. Cell host & microbe. 24(5):665-676 . PubMed
  42. Krueger A, et al. 2022. Front Microbiol. 12:789042. PubMed
  43. Beura LK, et al. 2018. Immunity. 48:327. PubMed
  44. Kar S, Colino J, Snapper C 2016. J Immunol. 196: 4204 - 4213. PubMed
  45. Tummers B, et al. 2020. Immunity. 52(6):994-1006.e8. PubMed
  46. Sakamoto K, et al. 2021. Immunity. 54:2321. PubMed
  47. Abdelfattah N, et al. 2022. Nat Commun. 13:767. PubMed
  48. Pizzurro GA, et al. 2021. Cancers (Basel). 13:. PubMed
  49. Chitu V, et al. 2020. Cell Reports. 30(9):3004-3019. PubMed
  50. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  51. Montalban-Arques A, et al. 2021. Cell Host Microbe. :. PubMed
  52. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  53. Mujal AM, et al. 2022. Cancer Immunol Res. 10:403. PubMed
  54. Schmit T, et al. 2022. Cell Rep. 38:110456. PubMed
  55. Sakamoto K, et al. 2022. STAR Protoc. 3:101052. PubMed
  56. Maller O, et al. 2020. Nat Mater. 20:548. PubMed
  57. Zhang L, et al. 2020. Cell. 442:181. PubMed
  58. O'Boyle C, et al. 2020. Int J Stroke. 0.746527778. PubMed
  59. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  60. Pastor Arroyo EM, et al. 2022. Clin Sci (Lond). 136:557. PubMed
  61. Ichinose M, et al. 2021. Sci Rep. 7200:11. PubMed
RRID
AB_2562630 (BioLegend Cat. No. 128037)

Antigen Details

Structure
14-17 kD protein (134 amino acids), member of the Ly-6 family of GPI linked protein. Ly6 family members share structure homology throughout a distinctive cystein rich protein domain that incorporates O-linked carbohydrates.
Distribution

Ly-6C is expressed primarily on bone marrow myeloid populations, monocytes/macrophages, neutrophils, endothelial cells, and some T cell subsets. Ly-6C is also a marker of memory CD8+ T cells.

Cell Type
Endothelial cells, Macrophages, Monocytes, Neutrophils, T cells
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819.
2. Cerwenka A, et al. 1998. J. Immunol. 161:97.

Gene ID
17067 View all products for this Gene ID
UniProt
View information about Ly-6C on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All Ly-6C Reagents Request Custom Conjugation
Description Clone Applications
Pacific Blue™ anti-mouse Ly-6C HK1.4 FC
APC anti-mouse Ly-6C HK1.4 FC
Purified anti-mouse Ly-6C HK1.4 FC,IHC-F
Biotin anti-mouse Ly-6C HK1.4 FC
FITC anti-mouse Ly-6C HK1.4 FC
Alexa Fluor® 647 anti-mouse Ly-6C HK1.4 FC
PE anti-mouse Ly-6C HK1.4 FC
PerCP/Cyanine5.5 anti-mouse Ly-6C HK1.4 FC
PE/Cyanine7 anti-mouse Ly-6C HK1.4 FC
Alexa Fluor® 488 anti-mouse Ly-6C HK1.4 FC
Alexa Fluor® 700 anti-mouse Ly-6C HK1.4 FC
APC/Cyanine7 anti-mouse Ly-6C HK1.4 FC
PerCP anti-mouse Ly-6C HK1.4 FC
Brilliant Violet 570™ anti-mouse Ly-6C HK1.4 FC
Brilliant Violet 421™ anti-mouse Ly-6C HK1.4 FC
Brilliant Violet 510™ anti-mouse Ly-6C HK1.4 FC
Brilliant Violet 605™ anti-mouse Ly-6C HK1.4 FC
Brilliant Violet 711™ anti-mouse Ly-6C HK1.4 FC
Purified anti-mouse Ly-6C (Maxpar® Ready) HK1.4 FC,CyTOF®
Brilliant Violet 785™ anti-mouse Ly-6C HK1.4 FC
PE/Dazzle™ 594 anti-mouse Ly-6C HK1.4 FC
APC/Fire™ 750 anti-mouse Ly-6C HK1.4 FC
TotalSeq™-A0013 anti-mouse Ly-6C HK1.4 PG
Brilliant Violet 650™ anti-mouse Ly-6C HK1.4 FC
TotalSeq™-C0013 anti-mouse Ly-6C HK1.4 PG
TotalSeq™-B0013 anti-mouse Ly-6C HK1.4 PG
APC/Fire™ 810 anti-mouse Ly-6C Antibody HK1.4 FC
Spark UV™ 387 anti-mouse Ly-6C HK1.4 FC
PE/Fire™ 810 anti-mouse Ly-6C HK1.4 FC
Spark Blue™ 550 anti-mouse Ly-6C (Flexi-Fluor™) HK1.4 FC
Spark Blue™ 574 anti-mouse Ly-6C (Flexi-Fluor™) HK1.4 FC
PE/Cyanine5 anti-mouse Ly-6C HK1.4 FC
Go To Top Version: 2    Revision Date: 12/09/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account